Supernus Pharmaceuticals Claimed Company
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system. read more
HR or Marketing? Claim Your Free Employer Account
Stefan K. F. Schwabe M.D., Ph.D. ā Chief Medical Officer and Executive Vice President of Research & Development at Supernus Pharmaceuticals
Executive Bio
Dr. Stefan K. F. Schwabe, MD, Ph.D. has been the Chief Medical Officer and Executive Vice President of Research & Development at Supernus Pharmaceuticals, Inc. (Former Name: Shire Laboratories, Inc.) since July 9, 2012. Dr. Schwabe has more than 20 years of experience in developing pharmaceutical products in the central nervous system (CNS). Dr. Schwabe served as Chief Operating Officer at DemeRx since 2010. From 2006 to 2010 Dr. Schwabe served as Vice-President for Project Direction for Neurology Projects at Sanofi-Aventis and from 2004 to 2006 he served as the Executive Director, US Clinical Development and Medical Affairs, Neuroscience for Novartis. From 1998 to 2004, Dr. Schwabe served as the Global Project Leader - Topamax for Johnson & Johnson. Dr. Schwabe served as Medical Director at Gabitril & Seroxat in the Health Care Strategy Unit, International Operations for Novo Nordisk and both International Project Team Leader and International Clinical Team Leader - Trileptal and Scientific Investigator for Ciba-Geigy. Dr. Schwabe also served as Chief Resident, Department of Neurology for the Medical College of Wisconsin in Milwaukee, Wisconsin. Dr. Schwabe holds a Bachelor Science in Chemistry from Florida International University, an M.D. from the Ludwig-Maximilians University in Munich, Germany and his Ph.D./Doctorate from the Department of Toxicology at the Technical University of Munich, Germany.
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Chief Medical Officer and Executive Vice President of Research & Development
$367k
$1.22M
Executive Team Culture Ratings from Supernus Pharmaceuticals Employees
BOTTOM
40%
Supernus Pharmaceuticals' Executive Team scores in the Bottom 40%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Supernus PharmaceuticalsSupernus Pharmaceuticals' Executive Team at a Glance
Based on 10 ratings, Supernus Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āCā or 64/100.
Supernus Pharmaceuticals' Executive Team ranks in the Bottom 40% of other companies in Washington, DC and Bottom 40% of other companies on Comparably that also have 201-500 Employees.
×